Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20697094

J. Clin. Oncol. 2010 Oct 10 28 29 4485-91

Download in:

View as

General Info

PMID
20697094